Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 8—August 2003

Rickettsia felis in the United Kingdom

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Rickettsia felis is a bacterium transmitted by the cat flea (Ctenocephalides felis), which also acts as a reservoir by means of transovarial transmission (13). The distribution of R. felis is potentially as wide as that of its insect host, and to date, its presence has been confirmed in cat flea populations in North and South America and southern Europe (4,5). R. felis was first identified as a human pathogen in 1994 (6), and cases of “flea-borne spotted fever,” which have signs and symptoms of febrile exanthema, have now been reported in the United States, Mexico, Brazil, France, and Germany (7,8). To our knowledge, reports on the presence of R. felis, or indeed any other spotted fever group rickettsia, in the United Kingdom have not been published.

To determine whether R. felis is present in the United Kingdom, we surveyed cat fleas collected from dogs and cats seen at veterinary practices in southern England and Northern Ireland. A total of 31 dogs and 79 cats from veterinary practices in Bristol, Dorset, London, Devon, Gloucestershire, Hampshire, and Antrim were included in our study. Fleas were collected by combing these animals for 10 minutes. All fleas from each animal were pooled in 70% ethanol. A total of 316 Ct. felis (Bouché, 1835), identified by using accepted morphologic criteria, were obtained, with each animal yielding one to five fleas. DNA was extracted from each of the 110 flea pools by using a standard silica cartridge method (QiaAmp DNA mini kit, QIAGEN Ltd., Crawley, West Sussex, U.K.) using the manufacturer’s instructions for tissue DNA extraction. The presence of rickettsial DNA was determined by using the polymerase chain reaction (PCR) with oligonucleotide primers that target rickettesial ompB (5) or gltA (2) genes. Positive control material was cultured R. felis. Rigorous controls to limit contamination were carried out, including the use of separate, dedicated rooms for DNA extraction, PCR setup, and gel analysis. Amplification products obtained from ompB and gltA PCRs were analyzed by using DNA sequencing. Sequences obtained were edited by using BioEdit (available from: URL: Similarity to published sequences was determined with the BLAST program (available from: URL: hosted by the National Centre for Biotechnology Information.

Eighteen flea DNA pools were positive for spotted fever group rickettsia. All 18 yielded PCR products with both ompB and gltA-targeting PCRs. The ompB and gltA DNA sequences of all PCR products were 100% identical to those published for R. felis, thereby providing evidence for the presence of R. felis in fleas collected from >16% of the animals surveyed. PCR-positive fleas were collected from 4 dogs and 14 cats from Bristol, Hampshire, Dorset, and Northern Ireland. Taking into account the number of fleas in each pool, we estimate that 6% to 12% of the fleas collected were infected with R. felis.

This study represents the first description of a spotted fever group rickettsia endemic to the United Kingdom. The species detected, R. felis, has clear public health implications. The bacterium appears to be widely distributed within the country, infecting a geographically dispersed population of Ct. felis. Up to 12% of Ct. felis may be infected with R. felis, a flea that is by far the most common species of ectoparasite encountered on cats and dogs in the U.K. mainland. Furthermore, Ct. felis often feeds on humans.

Clinicians encountering patients with fever or rash (or both) and a history of cat contact or flea bites should consider a diagnosis of R. felis. Laboratory confirmation of infection is not easy, but in vitro culture of R. felis, and hence material for a serologic assay for the diagnosis of human R. felis infections, has recently been described, and serology appears to be an accurate indicator of exposure (9). As with other spotted fever group rickettsial infections, molecular diagnostics may provide a useful alternative approach to detecting and identifying R. felis in infected tissues. In culture, R. felis has been shown to be resistant to erythromycin (unlike other rickettsia), gentamicin, amoxicillin, and trimethoprim-sulfamethoxazole. Thus, infection with this bacterium should be considered in cases of antibiotic-insensitive fever with a rash, especially in young, old, and immunosuppressed persons. The organism is sensitive to doxycyclin, rifampicin, thiamphenicol, and fluoroquinolones (10)



We thank Alex Davies and Anne Seabright for assistance with collecting and processing the fleas and D. Raoult for providing Rickettsia felis.

Novartis UK provided financial assistance with this project.


Martin J. Kenny*, Richard J. Birtles†, Michael J. Day*, and Susan E. Shaw*Comments to Author 
Author affiliations: *University of Bristol, Langford, Somerset, United Kingdom; †University of Liverpool, Leahurst, Neston, Cheshire, United Kingdom



  1. Azad  AF, Sacci  JB Jr, Nelson  WM, Dasch  GA, Schmidtman  ET, Carl  M. Genetic characterization and transovarial transmission of a novel typhus-like rickettsia found in cat fleas. Proc Natl Acad Sci U S A. 1992;89:4362. DOIPubMedGoogle Scholar
  2. Higgins  JA, Radulovic  S, Schriefer  ME, Azad  AF. Rickettsia felis: a new species of pathogenic rickettsia isolated from cat fleas. J Clin Microbiol. 1996;34:6714.PubMedGoogle Scholar
  3. Bouyer  DH, Stenos  J, Crocquet-Valdes  P, Moron  CG, Popov  VL, Zavala-Velazquez  JE, Rickettsia felis: molecular characterization of a new member of the spotted fever group. Int J Syst Evol Microbiol. 2001;51:33947.PubMedGoogle Scholar
  4. Oliveira  RP, Galvao  MA, Mafra  CL, Chamone  CB, Calic  SB, Silva  SU, Rickettsia felis in Ctenocephalides spp. fleas, Brazil. Emerg Infect Dis. 2002;8:3179. DOIPubMedGoogle Scholar
  5. Marquez  FJ, Munain  MA, Perez  JM, Panchon  J. Presence of Rickettsia felis in the cat flea from southwestern Europe. Emerg Infect Dis. 2002;8:8991. DOIPubMedGoogle Scholar
  6. Schriefer  ME, Sacci  JB Jr, Dumler  JS, Bullen  MG, Azad  AF. Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J Clin Microbiol. 1994;32:94954.PubMedGoogle Scholar
  7. Richter  J, Fournier  PE, Petridou  J, Haussinger  D, Raoult  D. Rickettsia felis infection acquired in Europe and documented by polymerase chain reaction. Emerg Infect Dis. 2002;8:2078. DOIPubMedGoogle Scholar
  8. Zavala-Velazquez  JE, Ruiz-Sosa  JA, Sanchez-Elias  RA, Becerra-Carmona  G, Walker  DH. Rickettsia felis rickettsiosis in Yucatan. Lancet. 2000;356:107980.PubMedGoogle Scholar
  9. La Scola  B, Meconi  S, Fenollar  F, Rolain  JM, Roux  V, Raoult  D. Emended description of Rickettsia felis (Bouyer et al. 2001), a temperature-dependent cultured bacterium. Int J Syst Evol Microbiol. 2002;52:203541. DOIPubMedGoogle Scholar
  10. Rolain  JM, Stuhl  L, Maurin  M, Raoult  D. Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay. Antimicrob Agents Chemother. 2002;46:274751. DOIPubMedGoogle Scholar


Cite This Article

DOI: 10.3201/eid0908.030314

Related Links


Table of Contents – Volume 9, Number 8—August 2003

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Susan E. Shaw, Department of Clinical Veterinary Sciences, University of Bristol, Langford, Somerset, BS40 5DU, United Kingdom; fax: +44 (0)117 9289505

Send To

10000 character(s) remaining.


Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.